BlackRock Fund Advisors - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 170 filers reported holding HAEMONETICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2016$166,324,000
+27.0%
4,137,423
+14.4%
0.03%
+14.8%
Q3 2016$130,959,000
+35.6%
3,616,662
+8.6%
0.03%
+28.6%
Q2 2016$96,588,000
-14.7%
3,331,768
+2.9%
0.02%
-19.2%
Q1 2016$113,218,000
+8.5%
3,236,644
-0.0%
0.03%
+8.3%
Q4 2015$104,395,000
+5.5%
3,238,043
+5.8%
0.02%
-7.7%
Q3 2015$98,946,000
-20.8%
3,061,460
+1.4%
0.03%
-13.3%
Q2 2015$124,899,000
-9.0%
3,019,800
-1.1%
0.03%
-9.1%
Q1 2015$137,227,000
+26.7%
3,054,927
+5.5%
0.03%
+22.2%
Q4 2014$108,312,000
+17.3%
2,894,502
+9.5%
0.03%
+3.8%
Q3 2014$92,315,000
-4.1%
2,643,620
-3.1%
0.03%
-3.7%
Q2 2014$96,255,000
+2.1%
2,728,327
-5.7%
0.03%
-3.6%
Q1 2014$94,267,000
-21.1%
2,892,523
+2.0%
0.03%
-22.2%
Q4 2013$119,525,000
+8.4%
2,837,060
+2.6%
0.04%
-2.7%
Q3 2013$110,298,000
+8.9%
2,765,748
+13.0%
0.04%0.0%
Q2 2013$101,247,0002,448,5340.04%
Other shareholders
HAEMONETICS CORP shareholders Q3 2015
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders